Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amivantamab for Lung Cancer
Recruiting1 awardPhase 1
Tampa, Florida
This trial is testing a new drug to treat NSCLC, which is the most common type of lung cancer. The purpose of the study is to see if the drug is safe and effective, and to find the best dose.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.